Peroxisome Proliferator-Activated Receptors Associated with Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming a major cause of chronic liver disease worldwide. Concurrent to an increase in NAFLD prevalence, there is an increase in the obesity epidemic and the correlated insulin-resistant state. It is a challenge to diagnose NAFLD because many pati...
Main Authors: | Nan Wang, Rui Kong, Hui Luo, Xiaorong Xu, Jie Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2017/6561701 |
Similar Items
-
Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)
by: Yuan-Ye Qiu, et al.
Published: (2023-06-01) -
Peroxisome Proliferator-Activated Receptor-γ as a Target and Regulator of Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease
by: Mohamed Zaiou
Published: (2023-04-01) -
The role of peroxisome proliferator-activated receptor in the treatment of non-alcoholic fatty liver disease
by: Sun Xin, et al.
Published: (2017-03-01) -
Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease
by: Anne Fougerat, et al.
Published: (2020-07-01) -
Peroxisome proliferator-activated receptors and their novel ligands as candidates for the treatment of non-alcoholic fatty liver disease
by: Fougerat, Anne, et al.
Published: (2020)